Clinical Topics
-
When cisplatin won’t do, try carboplatin in head and neck cancer -
Is early-onset cancer an emerging global epidemic? -
Despite benefits, extended-interval pembro uptake remains low -
Time to cancer diagnoses in U.S. averages 5 months -
Trends in Palliative Care Utilization and Facility Type for Stage IV Esophageal Cancer: A National Cancer Database Analysis
Digital Edition
Conference Coverage
-
Multiprong strategy makes clinical trials less White -
CBSM phone app eases anxiety, depression in cancer patients -
Huge underuse of germline testing for cancer patients -
ACS officer provides ASCO highlights: Targeting hidden cancer, AI in oncology -
Metronomic chemotherapy performs well in second-line head and neck cancer -
Radiofrequency ablation successful in small thyroid cancers -
A farewell to arms? Drug approvals based on single-arm trials can be flawed -
Time to cancer diagnoses in U.S. averages 5 months -
Pembro/chemo combo fails to improve event-free survival in head and neck cancer -
First drug for desmoid tumors: ‘Impressive’ data for nirogacestat
Question 1 of 5
